Overview
Investors searching SHIB vs INJ usually want a clear market-cap and momentum snapshot. SHIB prints $0.000005 (+1.03%) while Injective is at $5.07 (+4.00%), with volume edge currently on SHIB.
Quick winners
Full comparison
| Metric | SHIB | INJ |
|---|---|---|
| Price | $0.000005 | $5.07 |
| Market Cap | $2.88B | $490.41M |
| FDV | — | — |
| Volume 24h | $5.20M | $2.62M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 31.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.94% | +5.78% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | SHIB | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +1.03% | +4.00% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | SHIB | INJ |
|---|---|---|
| RSI | 61.25 | 53.92 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.00 | 0.29 |
| ADX | 33.42 | 12.69 |
| Support | 0.00 | 4.91 |
| Resistance | 0.00 | 5.47 |
| Trend | bearish | neutral |
| Momentum | — | — |
| Signal | neutral | neutral |
Automatic technical analysis
Technically, SHIB shows RSI 61.25 with trend bias bearish, while Injective sits at RSI 53.92 (neutral). Divergences between momentum and price should be confirmed on higher timeframes.
Fundamentals
| Metric | SHIB | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
SHIB
Injective
Pros and cons
Pros of SHIB
- SHIB has an established coin page footprint on PEPS for continuous monitoring.
- Composite PEPS readings for SHIB can surface clearer module agreement during trend phases.
- SHIB often anchors narratives that attract sustained media and analyst coverage.
- Higher ranking for SHIB can translate into tighter spreads on major venues.
Cons of SHIB
- Regulatory or macro headlines can hit SHIB harder simply because it is more visible.
- When dominance narratives fade, SHIB can lag hotter rotation names.
- Crowded positioning around SHIB sometimes amplifies squeeze or flush risk.
Pros of Injective
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Diversifying versus SHIB with Injective can change portfolio factor exposure.
- If technical momentum aligns, Injective may outperform on medium-term windows.
Cons of Injective
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
- Trend failures on Injective often travel faster than on more established assets.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
Which looks stronger right now?
On the latest snapshot, market-cap leadership belongs to SHIB, while short-term performance leans toward Injective. That mix suggests relative strength can flip quickly, so size risk accordingly.
AI summary
For readers asking which is “better”, the honest answer is conditional. SHIB and Injective solve overlapping but not identical market jobs. On-chain and developer fields, when available, add slower-moving context beneath the tape. Missing fundamentals should be treated as unknown, not as zeros. If your thesis is long-term adoption, weight fundamentals and liquidity; if tactical, weight trend/momentum — and always define invalidation.
FAQ
Which is better, SHIB or Injective?
“Better” depends on horizon and risk. SHIB leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, SHIB or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both SHIB and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. SHIB currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.